| Literature DB >> 18400105 |
Balázs Tóth1, Martina Wilke, Frauke Stanke, Martina Dorsch, Silke Jansen, Dirk Wedekind, Nikoletta Charizopoulou, Alice Bot, Marion Burmester, Sabine Leonhard-Marek, Hugo R de Jonge, Hans-Jürgen Hedrich, Gerhard Breves, Burkhard Tümmler.
Abstract
BACKGROUND: A major boost to cystic fibrosis disease research was given by the generation of various mouse models using gene targeting in embryonal stem cells. Moreover, the introduction of the same mutation on different inbred strains generating congenic strains facilitated the search for modifier genes. From the original CftrTgH(neoim)Hgu mouse model with a divergent genetic background (129/Sv, C57BL/6, HsdOla:MF1) two inbred mutant mouse strains CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu had been generated using strict brother x sister mating. CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu mice were fertile and showed normal growth and lifespan. In this work the CftrTgH(neoim)Hgu insertional mutation was backcrossed from CF/3-CftrTgH(neoim)Hgu onto the inbred backgrounds C57BL/6J and DBA/2J generating congenic animals in order to clarify the differential impact of the Cftr mutation and the genetic background on the disease phenotype of the cystic fibrosis mutant mice. Clinical and electrophysiological features of the two congenic strains were compared with those of CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu and wild type controls.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18400105 PMCID: PMC2323021 DOI: 10.1186/1471-2156-9-28
Source DB: PubMed Journal: BMC Genet ISSN: 1471-2156 Impact factor: 2.797
Body weights of the investigated mice.
| 118.4 ± 8.3 | F 167-F 169 | 9 ♀ | 21.7 ± 0.5 | |
| 9 ♂ | 27.6 ± 2.6 | |||
| 113.7 ± 8.4 | F 166-F 170 | 9 ♀ | 21.2 ± 2.0 | |
| 9 ♂ | 31.7 ± 2.6 | |||
| 140.4 ± 2.1* | no data | 9 ♀ | 37.7 ± 4.8 | |
| 9 ♂ | 43.4 ± 5.1 | |||
| 114.6 ± 5.7 | N10F 9-F 12 | 9 ♀ | 20.8 ± 2.7 | |
| 9 ♂ | 23.7 ± 3.0 | |||
| 107.8 ± 8.9 | N12F 8-F 12 | 9 ♀ | 20.4 ± 0.9 | |
| 9 ♂ | 26.1 ± 2.1 | |||
| 111.9 ± 8.7 | F 27-F 40 | 9 ♀ | 25.4 ± 1.8 | |
| 9 ♂ | 29.9 ± 3.3 | |||
| 122.1 ± 8.1 | F 27-F 40 | 9 ♀ | 24.4 ± 2.9 | |
| 9 ♂ | 31.3 ± 2.5 | |||
| 112 | ♀ | Jaxpheno1: 24.4 | ||
| Jaxpheno2: 27.0 | ||||
| Jaxpheno5: 24.9 | ||||
| ♂ | Jaxpheno1: 28.6 | |||
| Jaxpheno2: 29.2 | ||||
| Jaxpheno5: 28.9 | ||||
| 112 | ♀ | Jaxpheno1 21.9 | ||
| Jaxpheno2: 22.0 | ||||
| Jaxpheno5: 22.1 | ||||
| ♂ | Jaxpheno1: 29.1 | |||
| Jaxpheno2: 30.5 | ||||
| Jaxpheno5: 30.0 |
* The body weight of HsdOla:MF1 mice by the age of 120 ± 9 days had been determined in a previous study [7] to be 31 ± 2 g.
§Data were obtained from the Mouse Phenome Database of the Jackson Laboratory, Bar Harbor, Maine, USA [33].
Significance of differences in mean body weight differentiated by strain and gender
| ♂ | ♀ | ♂ | ♀ | ♂ | ♀ | ♂ | ♀ | ♂ | ♀ | ♂ | ♀ | ♂ | ♀ | ||
| ♂ | *** | * | ** | na | na | ns | * | ns | *** | ns | ns | ns | ns | ||
| ♀ | *** | ns | na | na | ns | ns | ** | * | *** | ** | *** | * | |||
| ♂ | *** | na | na | ** | *** | ** | *** | ns | ** | ns | ** | ||||
| ♀ | na | na | ns | ns | * | ns | ** | * | *** | ns | |||||
| ♂ | * | na | na | na | na | na | na | na | na | ||||||
| ♀ | na | na | na | na | na | na | na | na | |||||||
| ♂ | ns | ns | ns | * | ns | ** | ns | ||||||||
| ♀ | * | ns | ** | * | *** | ns | |||||||||
| ♂ | *** | ns | ns | * | ns | ||||||||||
| ♀ | *** | ** | *** | * | |||||||||||
| ♂ | * | ns | * | ||||||||||||
| ♀ | ** | ns | |||||||||||||
| ♂ | ** | ||||||||||||||
| ♀ | |||||||||||||||
*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant na, not applicable because of the higher age of HsdOla:MF1 mice
Fertility of mouse strains
| Median (inner quartiles; range) | ||||
| DBA/2J | F 167-F 169 | 7 | 4 (3–7; 1–14) | 4 (2–5; 1–8) |
| C57BL/6J | F 166-F 170 | 68 | 6 (5–8; 2–10) | 6 (4–8; 1–11) |
| D2.129P2(CF/3)- | N10F 9-F 12 | 19 | 4 (3–7; 1–10) | 4 (2–5; 1–10) |
| B6.129P2(CF/3)- | N12F 8-F 12 | 21 | 4 (3–5; 1–7) | 5 (3–7; 1–11) |
| CF/1- | F 27-F 40 | 106 | 3 (2–4; 1–10) | 5 (3–6; 1–10) |
| CF/3- | F 27-F 40 | 93 | 3 (2–3; 1–8) | 6 (4–7; 1–10) |
Significance of interstrain differences of fertility (litter size and number of litters per breeding pair)
| DBA/2J | C57BL/6J | D2-CF/3 | B6-CF/3 | CF/1 | CF/3 | |
| DBA/2J | ns | ns | ns | *** | *** | |
| C57BL/6J | ns | ns | ** | *** | *** | |
| D2-CF/3 | ns | ** | ns | *** | *** | |
| B6-CF/3 | ns | ns | ns | ns | * | |
| CF/1 | ns | *** | * | ns | ns | |
| CF/3 | * | ns | *** | ns | ** | |
*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant
Figure 1Short circuit current measurements in the epithelia of the upper respiratory tract (A, B, n = 4 per mouse line), ileum (C, D, n = 4) and colon epithelium (E, n = 10) in inbred Cftrmouse strains and their cognate wild type controls. ΔIsc represents the change in short circuit current from baseline after addition of either amiloride (A), forskolin (B), forskolin + genistein (D) and carbachol (C, E). * P < 0.05; ** P < 0.01; *** P < 0.001.